GSK-3β inhibitors reverse cocaine-induced synaptic transmission dysfunction in the nucleus accumbens

Synapse. 2016 Nov;70(11):461-70. doi: 10.1002/syn.21922. Epub 2016 Jul 22.

Abstract

Nucleus accumbens receives glutamatergic projection from the prefrontal cortex (PFC) and dopaminergic input from the Ventral tegmental area (VTA). Recent studies have suggested a critical role for serine/threonine kinase glycogen synthase kinase 3β (GSK3β) in cocaine-induced hyperactivity; however, the effect of GSK3β on the modulation of glutamatergic and dopaminergic afferents is unclear. In this study, we found that the GSK3 inhibitors, LiCl (100 mg/kg, i.p.) or SB216763 (2.5 mg/kg, i.p.), blocked the cocaine-induced hyperlocomotor activity in rats. By employing single-unit recordings in vivo, we found that pretreatment with either SB216763 or LiCl for 15 min reversed the cocaine-inhibited firing frequency of medium spiny neuron (MSN) in the nucleus accumbens (NAc). Preperfusion of SB216763 (5 μM) ameliorated the inhibitory effect of cocaine on both the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) (up to 99 ± 6.8% inhibition) and N-methyl-D-aspartic acid receptor (NMDAR)-mediate EPSC (up to 73 ± 9.7% inhibition) in the NAc in brain slices. The effect of cocaine on AMPA and NMDA receptor-mediate excitatory postsynaptic current (EPSC) were mimicked by the D1 -like receptor agonist SKF 38393 and blocked by the D1 -like receptor antagonist SCH 23390, whereas D2 -like receptor agonist or antagonist failed to mimic or to block the action of cocaine. Preperfusion of SB216763 for 5 min also ameliorated the inhibitory effect of SKF38393 on both AMPA and NMDA receptor-mediated components of EPSC, indicate the effect of SB216763 on cocaine was via the D1 -like receptor. Moreover, cocaine inhibited the presynaptic release of glutamate in the NAc, and SB216763 reversed this effect. In conclusion, D1 receptor-GSK3β pathway, which mediates glutamatergic transmission in the NAc core through a presynaptic mechanism, plays an important role in acute cocaine-induced hyperlocomotion.

Keywords: D1 receptor; GSK3β; NAc; cocaine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Benzazepines / pharmacology
  • Cocaine / pharmacology*
  • Dopamine Uptake Inhibitors / pharmacology*
  • Enzyme Inhibitors / pharmacology*
  • Excitatory Postsynaptic Potentials*
  • Glycogen Synthase Kinase 3 beta / antagonists & inhibitors*
  • Indoles / pharmacology
  • Lithium Chloride / pharmacology
  • Male
  • Maleimides / pharmacology
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors

Substances

  • Benzazepines
  • Dopamine Uptake Inhibitors
  • Enzyme Inhibitors
  • Indoles
  • Maleimides
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • SB 216763
  • SCH 23390
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Glycogen Synthase Kinase 3 beta
  • Lithium Chloride
  • Cocaine